In parallel with the bone marrow lactic acid concentration, the progression of allodynia and thermal hyperalgesia was significantly suppressed by MCT4 knockdown in SAS cells seven days after the cancer cell injection (Figure 5B). The gene discussed is SLC16A3; the disease is cancer.